Interceptive effect of p-propoxybenzoic acid against DMBA-induced breast cancer in female sprague dawley rats through PTP1B inhibition
Medical Oncology · 09.11.2026 · 43 (12)
DOI: 10.1007/s12032-026-03494-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 09.11.2026. Verfasst von Keval Raval und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, Changa, Anand, Gujarat, 388421, India. Kevalrava…. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 1, Mammary Neoplasms, Experimental, Benzoates. Die Arbeit nennt 90 Literaturangaben.
Abstract (Originalsprache)
Protein tyrosine phosphatase 1B (PTP1B) promotes breast cancer progression through oncogenic signaling. p-propoxybenzoic acid (p-PBA) is a phytoconstituent with reported anti-proliferative and anti-mitotic activity, potentially mediated through PTP1B inhibition. Therefore, p-PBA was hypothesized to exert an ameliorative effect against 7,12-dimethylbenz(α)anthracene (DMBA)-induced breast cancer through PTP1B inhibition. Forty-eight rats were divided into six groups. Excluding the normal control group, all animals received DMBA (50 mg/kg; subcutaneously) for tumor induction. Three groups received p-PBA (50, 100, or 150 mg/kg/day) orally for 20 weeks, including 2 weeks of pretreatment. The standard control group received tamoxifen (4 mg/kg; intraperitoneally) twice weekly for 20 weeks. Tumor onset was monitored for 20 weeks. At Week 20, morphological changes were examined. Subsequently, tumor volume (TV), tumor weight (TW), blood glucose levels (BGLs), blood parameters, oxidative biomarkers, hepatic injury biomarkers, and pro-inflammatory cytokines were evaluated. PTP non-receptor 1 (PTPN1) expression was evaluated through gene expression analysis and histopathology of tumor tissues was performed to assess the protective effects of p-PBA. p-PBA significantly delayed tumor onset and reduced the morphological damage. P-PBA treatment significantly reduced TV, TW, and BGLs. The p-PBA (100 mg/kg) and p-PBA (150 mg/kg) groups significantly regulated the levels of blood parameters. p-PBA significantly modulated oxidative biomarkers, hepatic injury biomarkers, and pro-inflammatory cytokines. Gene expression analysis indicated a significant PTPN1 downregulation in p-PBA-treated animals. Histopathological analysis revealed a protective effect of p-PBA in preventing the progression of breast cancer. p-PBA exhibited an ameliorative effect on DMBA-induced breast cancer, potentially through PTP1B inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, Changa, Anand, Gujarat, 388421, India. Kevalraval.ph@charusat.ac.in.
- School of Pharmacy, RK University, Rajkot, Gujarat, India. Kevalraval.ph@charusat.ac.in.
- Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, Changa, Anand, Gujarat, 388421, India.
- School of Pharmacy, RK University, Rajkot, Gujarat, India.
- Parul Institute of Pharmaceutical Education and Research, Parul University, Gujarat, 391760, Vadodara, India.
ORCID-Profile: Keval Raval
Zitieren
APA
Raval, K., Patel, A., & Tirgar, P. (2026). Interceptive effect of p-propoxybenzoic acid against DMBA-induced breast cancer in female sprague dawley rats through PTP1B inhibition. Medical Oncology, 43(12). https://doi.org/10.1007/s12032-026-03494-1
Vancouver
Raval K, Patel A, Tirgar P. Interceptive effect of p-propoxybenzoic acid against DMBA-induced breast cancer in female sprague dawley rats through PTP1B inhibition. Medical Oncology. 2026;43(12). doi:10.1007/s12032-026-03494-1
BibTeX
@article{Raval2026,
author = {Raval, Keval and Patel, Alkeshkumar and Tirgar, Pravin},
title = {Interceptive effect of p-propoxybenzoic acid against DMBA-induced breast cancer in female sprague dawley rats through PTP1B inhibition},
journal = {Medical Oncology},
year = {2026},
volume = {43},
number = {12},
doi = {10.1007/s12032-026-03494-1}
}
EUVIMED